Location History:
- Paris, FR (2014)
- Antony, FR (2022)
Company Filing History:
Years Active: 2014-2022
Title: Celine Jaillard: Innovator in Neurodegenerative Disease Research
Introduction
Celine Jaillard is a prominent inventor based in Paris, France. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing pharmaceutical compositions aimed at treating conditions such as Alzheimer's disease.
Latest Patents
Celine Jaillard's latest patents include groundbreaking inventions that address neurodegenerative disorders. One of her notable patents is titled "Neuronal viability factor and use thereof in Alzheimer's disease." This invention concerns a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a compound selected from a specific group, including polypeptides and polynucleotides. The composition is designed for the manufacture of a medicament aimed at treating or preventing neurodegenerative disorders.
Another significant patent is "Neuronal viability factor and use thereof," which relates to methods and compositions for the detection and treatment of neurodegenerative diseases. This invention focuses on polypeptides that can protect against neuron degeneration, as well as nucleic acid molecules that encode these polypeptides and antibodies that recognize them.
Career Highlights
Celine Jaillard has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her career is marked by a commitment to advancing research in neurodegenerative diseases and developing effective treatments.
Collaborations
Throughout her career, Celine has collaborated with notable colleagues, including Thierry Leveillard and Jose-Alain Sahel. These collaborations have further enriched her research and contributed to her innovative work in the field.
Conclusion
Celine Jaillard is a trailblazer in the realm of neurodegenerative disease research, with her patents reflecting her dedication to finding solutions for these challenging conditions. Her contributions continue to pave the way for advancements in medical treatments and therapies.